Home
Medicines
Active ingredients
Companies
Advanced search
Adverse event reporting
Login
Home
Medicines
Active ingredients
Companies
Advanced search
Adverse event reporting
Login
menu
Home
Active ingredients
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)
Medicine
Status
PIL
SPC
Legal Category
Active Ingredients
Company
Covid-19 Vaccine Janssen
Updated
PIL
04/06/21
SPC
04/06/21
A
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)
Janssen Sciences Ireland
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)
